DUSP1 Antibody (LS-B2736)

貨號 Cat. No.
LS-B2736
規格 Size
50 µg
品牌 Brand
LSBio

Description





















































































Antibody Catalog ID: LS-B2736
Antibody Validation: This antibody replaces catalog number LS-C54743. It has been validated for use in the following assays: IHC-P.
Antibody Target: Dual Specificity Protein Phosphatase 1 (DUSP1/MKP1)
Synonyms: DUSP1, 3CH134, cl100, dual specificity phosphatase 1, dusp1, ERK-inactivating phosphatase , hvh1, map kinase phosphatase 1, mitogen-activated kinase phosphatase-1, MKP-1, MKP1, protein tyrosine phosphatase non-receptor type 10, ptpn10, VH1, YVH1
Family: Protein Phosphatase
Subfamily: Dual specificity MKP
Host: DUSP1 antibody was produced in Goat
Antigen Species: DUSP1 antibody was raised against Human
Clonality: Polyclonal
Antigen Type: Synthetic peptide
Immunogen: DUSP1 antibody was raised against synthetic peptide (SYLQSPITTSPSC) from C-terminus of human DUSP1
Antigen Modification: C-Terminus
Predicted Species Reactivity: Mouse, Rat
Purification: Immunoaffinity Chromatography
Presentation: Tris saline, 0.02% sodium azide, pH 7.3, 0.5% BSA
Recommended Storage: +4°C or -20°C, Avoid repeated freezing and thawing.
Antibody Usage Summary: Immunohistochemistry: LS-B2736 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D3, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2736 was determined to be 3.75 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (3.75 µg/ml), Western blot (WB) (0.3 - 1 µg/ml), ELISA (1:32000) (Optimal dilution to be determined by the researcher)
Size: 50 µg
Concentration: 0.5 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢